维普中文期刊产品整合服务
29篇 您的检索式:作者名="HISSARS"
    题名 作者 年代 出处 被引量
1Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment显示文摘BACKGROUND: Treatment of chronic hepatitis B (CHB) alone with interferon or lamivudine alone or in combination is effective in only a small proportion of patients. Treatment of patients in whom antiviral therapy fails is challenging. This study was made to determine the efficacy of combined pegylated interferon alpha (peg-IFN) and lamivudine in patients with CHB who had failed to respond to antiviral treatment. METHODS: Twenty patients with CHB proven by liver biopsy, with ALT levels >1.5×ULN,HBV DNA levels>141 500 copies/ml, and previous treatment failure with an adequate regimen were treated with a combination of peg-IFN 1.5μg/kg and lamivudine 100 mg/day for 52 weeks and followed up for a further 24 weeks. Biochemical response was defined as normalization of ALT and DNA response as HBV DNA<141 500 copies/ml. Secondary efficacy measures included HBsAg loss, HBeAg loss and appearance of anti-HBe (in cases of HBeAg-positive patients). RESULTS: Twenty patients were treated, of whom 16 were HBeAg positive. At 52 weeks, normal ALT was seen in 10 (50%) (8 of 16 HBeAg+ and 2 of 4 HBeAg), HBV DNA response in 5 (25%) (5 of 16 in HBeAg+ and none in HBeAg-), and HBeAg loss with appearance of anti-HBe in 5 (31.3%) of the 16 HBeAg positive patients. At 76 weeks, 8 (80%) of the 10 patients with normal ALT at 52 weeks relapsed, with normal ALT only in 2 (10%) (1 of 16 HBeAg+ and 1 of 4 HBeAg-), and all 5 patients who had a DNA response at 52 weeks relapsed at 76 weeks and had no DNA response. HBeAg loss with appearance of anti-HBe was seen in 1 (6.3%) of 16 HBeAg-positive patients. None of the patients lost HBsAg. CONCLUSIONS: The combination of peg-IFN and lamivudine for 52 weeks is not effective for treatment of CHB patients with a failed treatment. New treatment strategies need to be developed.Shiv K.Sarin Manoj Kumar Syed Hissar Barjesh C.Sharma 2006Hepatobiliary & Pancreatic Diseases International2006,5,3:3
2Comparison of low - dosepegylated interferon versus standard high - dose pegylated in-terferon in combination with ribavirin in patients with chronichepatitis C with genotype 3 : an Indian experience显示文摘Sood A Midha V Hissar S 2008J Gas-troenterol Hepatol2008,23,2:1
3Decrease in CD4^ + T lymphocyte proliferation responses and enhanced CD150 cell expression in health care workers non - responsive to HBV vaccine 显示文摘Pati NT Sukriti Hissar S 2007Vaccine2007,25,10:1
4Virologic and histologie features of chronic hepatitis B virus - infected asymptomatic patients with per- sistently normal ALT显示文摘Kumar M Sarin SK Hissar S 2008Gastroenterology2008,134,5:1
5Decrease in CD4+ T lymphocyte proliferation responses and enhanced CD150 cell expression in health care workers non-responsive to HBV vaccine显示文摘Pati NT Hissar S Agrawal K 2007Vaccine2007,25,10:1
6Circulating tregs cor- relate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate显示文摘TrehanPati N Kotillil S Hissar SS 2011Clin Immunol2011,31,3:1
7Virologic and histologic features of chronic hepatitis B virusinfected asymptomatic patients with persistently normal ALT显示文摘Kumar M Sarin S K Hissar S 2008Gastroenterology2008,134,:1
8Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT显示文摘Kumar M Sarin SK Hissar S 2008Gastroenterology2008,134,5:1
9,Immunological mechanisms of hepatitis B virus persistence in newborns显示文摘Trehanpati N Hissar S Shrivastav S 2013The Indian journal of medical research2013,138,5:1
10Virologic and histologic features of chronic hepatitis B virus - infected asymptomatic patients with persistently normal AL T显示文摘KUMAR M SARIN SK HISSAR S 2008Gastroenterology2008,134,5:1
11ImmunologicalmechanismsofhepatitisBviruspersistenceinnewborns显示文摘TrehanpatiN HissarS ShrivastavS etal 2013IndianJMedRes2013,138,5:1
12Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT显示文摘Kumar M Sarin SK Hissar S 2008Gastroenterology2008,134,5:1
13Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: A case-control study of 213 hepatocellular carcinoma patients from India 显示文摘Kumar M Kumar R Hissar SS 2007Gastroenterol Hepatol2007,22,7:1
14Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis:a casecontrol study of 213 hepatocellular carcinoma patients from India显示文摘Kumar M Kumar R Hissar SS 0,,:1
15Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT显示文摘Kumar M Sarin SK Hissar S 2008Gastroenterology2008,134,5:1
16Virologicandhistologic features of chronic hepatitis B virus infected asymptomatic patients with persistently normal AL T显示文摘KUMARM SARINSK HISSARS 2008Gastroenterology2008,134,5:1
17Impaired monocyte‐macrophage functions and defective toll‐like receptor signaling in hepatitis E virus‐infected pregnant women with acute liver failure显示文摘Rashi Sehgal Sharda Patra Paul David Ashish Vyas Arshi Khanam Syed Hissar Ekta Gupta Guresh Kumar Shyam Kottilil Rakhi Maiwall Shiv Kumar Sarin Nirupama Trehanpati 2015Hepatology2015,,6:1
18Virologic and Histologic Features of Chronic Hepatitis B Virus-Infected Asymptomatic Patients With Persistently Normal ALT显示文摘Manoj Kumar Shiv K. Sarin Syed Hissar Chandana Pande Puja Sakhuja Barjesh Chander Sharma Ranjit Chauhan Sujoy Bose 2008Gastroenterology2008,,5:1
19Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT 显示文摘KUMAR M SARIN S K HISSAR S 2008Gastroenterology2008,134,5:1
20Virologic and histo- logic features of chronic hepatitis B virus infected asympto- matic patients with persistently normal ALT显示文摘KUMAR M SARIN SK HISSAR S 2008Gastroenter- ology2008,134,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费